Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lori Julin Wirth, M.D.

Co-Author

This page shows the publications co-authored by Lori Wirth and Sara Pai.
Connection Strength

1.182
  1. Checkpoint cluster: biomarkers of response. Emerg Top Life Sci. 2017 Dec 12; 1(5):501-508.
    View in: PubMed
    Score: 0.739
  2. Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model. Cancer Immunol Immunother. 2019 Aug; 68(8):1273-1286.
    View in: PubMed
    Score: 0.205
  3. PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4+ TILs in the Presence of PD-L1+ TAMs. Cancer Res. 2017 11 15; 77(22):6365-6374.
    View in: PubMed
    Score: 0.182
  4. A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma. Int J Radiat Oncol Biol Phys. 2021 01 01; 109(1):134-144.
    View in: PubMed
    Score: 0.056
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.